MGX Metagenomi Therapeutics, Inc.
$0.76▼ -1.54%
Healthcare
Other
Volume 29.7K
Avg Volume (10D) 169.9K
Key Metrics & Fundamentals
Market Cap
$28.54M
P/E Ratio
–
Div Yield
0.00%
52W Range
0.75 - 2.78
% vs 50 MA
-28.71%
% vs 200 MA
-41.52%
RSI-14
23.7
MACD Histogram
-0.0100
Beta (1Y vs SPY)
1.45
Free Cash Flow
-$19.64M
Gross Rev
-$257,000
Gross Profit
-$257,000
EBITDA
-$27.51M
COGS
–
Operating Exp
$28.52M
Operating Income
-$28.77M
EBIT
-$28.77M
Pretax Income
-$27.48M
Net Income
-$27.48M
EPS (Diluted)
-0.73
Price & Volume History
Loading chart…
Recent News
Metagenomi Therapeutics, Inc. to Participate in the Chardan 10th Annual Healthcare Conference
GlobeNewswire · Oct 13, 2026 8:00 AM ET
Metagenomi Therapeutics, Inc. to Present at the Wells Fargo 21st Annual Healthcare Conference
GlobeNewswire · Sep 1, 2026 8:00 AM ET
Metagenomi Therapeutics (MGX) Reports Q2 Loss, Lags Revenue Estimates
Zacks · Aug 10, 2026 5:55 PM ET
Metagenomi Therapeutics: Q2 Earnings Snapshot
Associated Press · Aug 10, 2026 4:47 PM ET
Metagenomi Therapeutics Reports Business Updates and Second Quarter 2026 Financial Results
GlobeNewswire · Aug 10, 2026 4:05 PM ET
Financial Overview - Income Statement
Quarterly
Mar 2026
See MGX's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.